MMCM
MRK icon

Murphy & Mullick Capital Management’s Merck MRK Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Buy
11,322
+2,308
+26% +$266K 1.01% 24
2025
Q4 		$949K Buy
9,014
+236
+3% +$22.2K 0.68% 32
2025
Q3 		$737K Buy
8,778
+532
+6% +$43.8K 0.55% 44
2025
Q2 		$651K Sell
8,246
-505
-6% -$40.1K 0.53% 47
2025
Q1 		$785K Sell
8,751
-419
-5% -$39.1K 0.76% 33
2024
Q4 		$912K Buy
+9,170
New +$945K 0.84% 28

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Murphy & Mullick Capital Management's MRK Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its Merck (MRK) stake by 26% in Q1 2026, buying an estimated $266K and bringing the position to 11,322 shares worth $1.36M. The position accounts for 1.01% of the portfolio, ranked #24.

Murphy & Mullick Capital Management first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Murphy & Mullick Capital Management held 11,322 shares of Merck worth $1.36M as of Q1 2026.
  • Murphy & Mullick Capital Management bought 2,308 Merck shares in Q1 2026, an estimated $266K.
  • Merck made up 1.01% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #24 holding.
  • Murphy & Mullick Capital Management first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.